SYNERA (Galen US Incorporated)


Welcome to the PulseAid listing for the SYNERA drug offered from Galen US Incorporated. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Ester Local Anesthetic [EPC],Esters [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Galen US Incorporated
NON-PROPRIETARY NAME: lidocaine and tetracaine
SUBSTANCE NAME: LIDOCAINE; TETRACAINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Ester Local Anesthetic [EPC],Esters [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: CUTANEOUS
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00


SYNERA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSYNERA from Galen US Incorporated
LABELER NAME: Galen US Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 70; 70(mg/1; mg/1)
START MARKETING DATE: 2013-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10885-002_34cbfcbb-47f1-3b60-e054-00144ff88e88
PRODUCT NDC: 10885-002
APPLICATION NUMBER: NDA021623

Other LIDOCAINE; TETRACAINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Galderma Laboratories, L.P.PLIAGLIS
Galen US IncorporatedSYNERA
Innovida Pharmaceutique CorporationLidocaine and Tetracaine